医学
抗凝剂
抗凝治疗
华法林
口服抗凝剂
药理学
肝素
拜瑞妥
药品
作者
Hongyan Zhang,Jing Ren
出处
期刊:Chin J Cardiovasc Med
日期:2019-12-25
卷期号:24 (6): 565-570
标识
DOI:10.3969/j.issn.1007-5410.2019.06.018
摘要
Anticoagulant drugs could be divided into oral anticoagulants and parenteral anticoagulants, the oral anticoagulants include the vitamin K antagonists and non-vitamin K antagonist oral anticoagulants; the parenteral anticoagulants include heparin drugs, bivalirudin and agartroban. Laboratory monitoring could help to improve the effectiveness and safety of anticoagulant therapy, but three questions need to be clarified: Which patients need to be monitored? Which experiments could be used for monitoring? How to understand monitoring data?
Key words:
Anticoagulants; Thrombosis; Hemorrhage; Drug monitoring
科研通智能强力驱动
Strongly Powered by AbleSci AI